Guadalupe M L Guerrero Avendaño, Armando B Martínez Avalos, Rocío N Gómez López, Sergio Gallegos Castorena, Juárez VL, Méndez PLR

Language: Spanish
References: 15
Page: 73-77
PDF size: 417.46 Kb.

ABSTRACT

One of the most important improvements in the treatment of Cancer in childhood is the percutaneous installation of permanent venous access. These are better applying in an angiographic room with a previous flebography of the limb where we plan to install the port; under fluoroscopic guidance and with the micro puncture technique. In the Hospital General de México we do all this to assure the correct installation of the venous access. In this paper, we review the roll of Interventional Radiology, and the comparison with other techniques.

REFERENCES

1. Hickman RO, Buckner CD, Clift RA, et al. A modified right atrial catheter for access to the venous system in marrow transplant recipients. Surg Gynecol Obstet 1979; 148: 871-875.

2. Niederhuber JE, Ensminger W, Gyres JW, et al. Totally implanted venous and arterial access system to replace external catheters in cancer treatment. Surgery 1982;92:706-712.

3. Winters V, Peters V, Coila S, et al. A trial with a new peripheral implanted vascular access device. Oncol Nurs Forum 1990;17:891-896.

4. James L, Bledsoe L, Hadaway LC. A retrospective look at tip collocation and complications of peripherally inserted central catheter lines. J Intraven Nurs 1993;16:104-109.

5. Raad II, Hohn DC, Gilbreath BJ, et al. Prevention of central venous catheter related infections by using maxime sterile barrier precautions during insertation. Infect Control Hosp Epidemiol 1994;15:231-238.

6. McCready D, Broadwater R, Ross M, et al. A case-control comparison of durability and cost between implanted reservoir and percutaneous catheters in cancer patients. J Surg Res 1991;51: 377-381.

7. Willard W, Coit D, Lucas A, Groeger JS. Long-term vascular access via the inferior vena cava. J Surg Oncol 1991;46: 162-166.

8. Ang P, Chia KH, Teoh MK, Wong KK. Use of a peripherally implanted subcutaneous permanent central venous access device for chemotherapy. The Singapore General Hospital Experience. Aust NZJ Med 2000; 30: 470-474.

9. D’ Angelo FA, Ramacciato G, Aurello P, Lauro S, Caramitti A, et al. Alternative insertion sites for permanent central venous access devices. Eur J Sug Oncol 1997; 23: 547-549.

10. Albo López C, López Rodríguez D, Constenla Camba MI, et al. Infectious and non-infectious complications of tunneled central catheters in hematologic patients. Sangre 1999; 44: 176-181.

11. Pintor E, Gomez C, Gonzalez J et al. Staphylococcus aureus bacteremia and a mass in the right atrium in a patient carrying a central port. Rev Esp Cardiol 1998; 51: 158-160.

12. Huu TC. Central Venous stenosis: review of the literature. Nephrologie 2001; 22:479-485.

13. Early and late complications of the use of life-cath type catheters in children with malignancies requiring urgent surgical intervention. Wiad Lek 1998; 51 suppl; 256-261.

14. Daeihagh P, Jordan J, Chen J, Rocco M. Efficacy of tissue plasminogen activator administration on patency of hemodialysis access catheters. Am J Kidney Dis 2000; 36: 75-79.

15. Apsner R, Muhm M, Unver B, Horl WH, et al. Expanding our interventional skills: